Peptides Lab
Retatrutide
5mg · Lyophilized
≥99.2% HPLC
Fat Loss & Metabolic
Retatrutide (LY3437943) — 5mg
GLP-1 / GIP / Glucagon triple agonist under investigation for metabolic research.
Select size
Price
€40
Payment: cryptocurrency only (BTC, ETH, XRP, SOL, USDT, USDC, XMR). Submit the contact form in your cart and we'll reply with the wallet address.
| CAS Number | 2381089-83-2 |
|---|---|
| Molecular Weight | 4731.4 g/mol |
| Purity | ≥99.2% |
| Form | Lyophilized powder |
| Storage | Store at -20°C. Stable at 2–8°C up to 30 days after reconstitution. |
Retatrutide (LY3437943) is a novel triple agonist peptide developed by Eli Lilly, simultaneously targeting the GLP-1, GIP, and glucagon receptors. In published phase II research, retatrutide demonstrated the largest body-weight reduction of any incretin-class agent studied to date, alongside marked improvements in hepatic steatosis markers. This product is intended exclusively for in-vitro and animal-model research applications.
Related research peptides
Peptides Lab
Tirzepatide
≥99.1% HPLC
Lyophilized
Fat Loss & Metabolic
Tirzepatide
CAS 2023788-19-2
From
€40
Peptides Lab
Semaglutide
≥99.0% HPLC
Lyophilized
Fat Loss & Metabolic
Semaglutide
CAS 910463-68-2
From
€50
Peptides Lab
Cagrilintide
≥99.0% HPLC
Lyophilized
Fat Loss & Metabolic
Cagrilintide
CAS 1415456-99-3
From
€75
Peptides Lab
CagriSema
≥99.0% HPLC
Lyophilized
Fat Loss & Metabolic
CagriSema (Cagrilintide + Semaglutide)
CAS 1415456-99-3 / 910463-68-2
From
€130